Cargando…
Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life
INTRODUCTION: Epidermal barrier dysfunction in children with atopic dermatitis can cause transcutaneous sensitization to allergens and allergic diseases. We evaluated the effectiveness of an early-intervention algorithm for atopic dermatitis treatment, utilizing pimecrolimus for long-term maintenanc...
Autores principales: | Murashkin, Nikolay N., Namazova-Baranova, Leyla S., Makarova, Svetlana G., Ivanov, Roman A., Grigorev, Stepan G., Fedorov, Dmitri V., Ambarchian, Eduard T., Epishev, Roman V., Materikin, Alexander I., Opryatin, Leonid A., Savelova, Alena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167287/ https://www.ncbi.nlm.nih.gov/pubmed/37181420 http://dx.doi.org/10.3389/fped.2023.1102354 |
Ejemplares similares
-
Pimecrolimus cream in the management of patients with atopic eczema
por: Spergel, Jonathan M
Publicado: (2009) -
Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?
por: Beriat, Güçlü Kaan, et al.
Publicado: (2012) -
Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
por: Huang, Chunyun, et al.
Publicado: (2014) -
Retraction: Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
Publicado: (2014) -
Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood
por: Boms, Stefanie, et al.
Publicado: (2004)